Considerations on The Biologic Gray Zone of Melanocytic Tumors

Giorgio Annessi; Emanuele Annessi

doi:10.5826/dpc.1402a154

Considerations on The Biologic Gray Zone of Melanocytic Tumors

Authors

Giorgio Annessi Dermatopathology Unit, Istituto Dermopatico dell’Immacolata, IRCCS, Roma, Italy
Emanuele Annessi Dermatopathology Unit, Istituto Dermopatico dell’Immacolata, IRCCS, Roma, Italy

Keywords:

Melanocytoma , Low grade melanoma, gray zone, histology

References

Elder DE, Barhnill R, Bastian BC, et al. “Melanocytic tumour classification and the pathway concept” in (2018) WHO Classification of Skin Tumours, 4th Edition, eds. Elder DE, Massi D, Scolyer RA, Willemze R, (lyon, F: IARC), pp 66-75.

Barhnill R, Bastian BC, Gerami et al. “Deep penetrating naevus and melanocytoma” in (2018) WHO Classification of Skin Tumours, 4th Edition, eds. Elder DE, Massi D, Scolyer RA, Willemze R, (lyon, F: IARC), pp 95-6.

Zembowicz A, Calonje E, Mihm MC Jr. “Pigmented epitheliod melanocytoma” in (2018) WHO Classification of Skin Tumours, 4th Edition, eds. Elder DE, Massi D, Scolyer RA, Willemze R, (lyon, F: IARC), pp. 978.

Wiesner T, Mihm MC Jr, Scolyer RA. “Combined naevus, including combined BAP1-inactivated naevus melanocytoma” in (2018) WHO Classification of Skin Tumours, 4th Edition, eds. Elder DE,, Massi D, Scolyer RA, Willemze R, (lyon, F: IARC), pp. 99-101.

Barhnill R, Bahrami A, Bastian BC, et al. “Spitz tumours” in (2018) WHO Classification of Skin Tumours, 4th Edition, eds. Elder DE,, Massi D, Scolyer RA, Willemze R, (lyon, F: IARC), pp. 108-10.

de la Fouchardiere A, Blokx W, van Kempen LC, Luzar B, et al. ESP, EORTC, and EURACAN Expert Opinion practical recommendation for the pathological diagnosis and clinical management of intermediate melanocytic tumors and rare melanoma variants. Virch Arch 2021;479:3-11.

Biologic gray zone of melanocityc tumors in reality: defining “non-conventional” melanocytic tumors. Ferrara G, Gualandi A, Rizzo N. Dermatology Practical and Conceptual 2024 (in press)

Keung EZ, Gershenwald JE. The eight edition American Joint Committee on Cancer (AJCC) melanoma staging system implications for melanoma treatment and care. Expert Rev Anticancer Ther 2018;18:775-784.

Borderline and malignant fibroblastic/myofibroblastic tumors. In (2014) Enzinger & Weiss’s Soft Tissue Tumors, 6th edn. Goldblum JR, Folpe AL, Weiss SW (Elsevier), pp. 288-340.